Impact of Active Surveillance and Contact Isolation on Transmission of Methicillin-resistant Staphylococcus aureus in Intensive Care Units in an Area With High Prevalence

Journal of the Formosan Medical Association

Volumn 109, Issue 4, 2010, Pages 258-268

  Wang, Jann Tay ^a   Lauderdale, Tsai Ling ^b   Lee, Wen Sen ^c   Huang, Jeng Hua ^d   Wang, Tsung Hsi ^e   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CATHAY GENERAL HOSPITAL   (Taiwan)

^e CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

intensive care units; methicillin resistant Staphylococcus aureus; patient isolation; surveillance

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CHRONIC KIDNEY FAILURE; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PREVALENCE; RESPIRATORY TRACT DISEASE; SPUTUM CULTURE; THROAT CULTURE; UROGENITAL TRACT DISEASE;

ADULT; AGED; CROSS INFECTION; FEMALE; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PROGRAM EVALUATION; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; TAIWAN; TIME FACTORS;

EID: 77952315131     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60051-4     Document Type: Article

References (36)

1. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32 (2004) 470-485
2. Wang J.T., Fang C.T., Chen Y.C., et al. Staphylococcal cassette chromosome mec in MRSA, Taiwan. Emerg Infect Dis 13 (2007) 494-497
3. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24 (2003) 362-386
4. Huang S.S., and Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 36 (2003) 281-285
5. Siegel J.D., Rhinehart E., Jackson M., et al. Management of Multidrug-resistant Organisms in Healthcare Settings (2006), Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee, Atlanta, GA
6. Boyce J.M. New insights for improving hand hygiene and practice. Infect Control Hosp Epidemiol 25 (2004) 187-188
7. Ridenour G., Lampen R., Federspiel J., et al. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 28 (2007) 1155-1161
8. Huang S.S., Yokoe D.S., Hinrichsen V.L., et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 43 (2006) 971-978
9. Salgado C.D., and Farr B.M. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures?. Infect Control Hosp Epidemiol 27 (2006) 116-121
10. Singh N., Squier C., Wannstedt C., et al. Impact of an aggressive infection control strategy on endemic Staphylococcus aureus infection in liver transplant recipients. Infect Control Hosp Epidemiol 27 (2006) 122-126
11. Cepeda J.A., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohort to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365 (2005) 295-304
12. Gould I.M., MacKenzie F.M., MacLennan G., et al. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents 29 (2007) 536-543
13. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2999 (2008) 1149-1157
14. Harbarth S., Masuet-Aumatell C., Schrenzel J., et al. Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care 10 (2006) R25
15. Chang S.C., Sun C.C., Yang L.S., et al. Increasing nosocomial infections of methicillin-resistant Staphylococcus aureus at a teaching hospital in Taiwan. Int J Antimicrob Agents 8 (1997) 109-114
16. Ho M., McDonald L., Lauderdale T., et al. Surveillance of antibiotic resistance in Taiwan, 1998. J Microbiol Immunol Infect 32 (1999) 239-249
17. Hsueh P.R., Chen W.H., Teng L.J., et al. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 26 (2005) 43-49
18. Wang J.T., Sheng W.H., and Chang S.C. Isolation precautions in hospitals. Nosocomial Infect Control J 12 (2002) 376-381
19. Yu W.L., Chang W.H., and Chuang Y.C. Nosocomial infections and surveillance for drug-resistant bacteria. Infect Control J 17 (2007) 254-262
20. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definition for nosocomial infections, 1988. Am J Infect Control 16 (1988) 128-140
21. Papia G., Louie M., Tralla A., et al. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective?. Infect Control Hosp Epidemiol 20 (1999) 473-477
22. Sanford M.D., Widmer A.F., Bale M.J., et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 19 (1994) 1123-1128
23. Salgado CD, Sheppe S, Dill J. The sensitivity of MRSA follow-up cultures. Presented at the 11th Annual Meeting of the Society for Healthcare Epidemiology of America; April 1-3, 2001; Toronto, Ontario, Canada. Abstract 40.
24. Shahin R., Johnson I.L., Jamieson F., et al. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med 153 (1999) 864-868
25. Clinical and Laboratory Standards Institute (CLSI): Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2 - A9. CLSI documents, Wayne, PA, 2006.
26. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
27. Chow J.W., and Yu V.L. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents 11 (1999) 7-12
28. Smolyakov R., Borer A., Riesenberg K., et al. Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J Hosp Infect 54 (2003) 32-38
29. Harris A.D., Smith D., Johnson J.A., et al. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 34 (2002) 340-345
30. Levin A.S., Levy C.E., Manrique A.E., et al. Severe nosocomial infections with imipenem-resistant Acinetobacter baumannii treated with ampicillin/sulbactam. Int J Antimicrob Agents 21 (2003) 58-62
31. Oleinick A., and Mantel N. Family studies in systemic lupus erythematosus. II. Mortality among siblings and offspring of index cases with a statistical appendix concerning life table analysis. J Chronic Dis 22 (1970) 617-624
32. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 148 (2008) 409-418
33. Garner J.S., Jarvis W.R., Emori T.G., et al. CDC definitions for nosocomial infections, 1988. Am J Infection Control 16 (1988) 128-140
34. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
35. Taiwan Nosocomial Infections Surveillance System (TNIS). Annual Report of Nosocomial Infections, 2007 (2008), TNIS, Taipei
36. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 35 (2007) 73-85